Fig. 5From: Next-generation sequencing to guide cancer therapyA representative clinical example of how NGS is utilized in recurrent lung adenocarcinoma. The illustrative case from the text has been fitted to the outline in Fig. 1. In a lung adenocarcinoma, there are a number of actionable mutations; this case shows a canonical EGFR mutation, treated with erlotinib. There are actually now two levels of resistance that can develop, illustrated in rows 3 and 4. FFPE formalin-fixed, paraffin-embedded specimenBack to article page